| HGNC Family | Non-coding RNAs |
| Name | microRNA 2392 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR-2392 has emerged as an important regulator in cancer progression. In gastric cancer, it is down-regulated in tumor tissues and cell lines, and its overexpression significantly suppresses invasion and metastasis via direct targeting of oncogenic mediators such as MAML3 and WHSC1, thereby inhibiting epithelial‐mesenchymal transition and correlating with better patient survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In a separate study on hepatocellular carcinoma, the lncRNA CACNA1G‑AS1 was found to promote tumor progression by sponging miR-2392, which normally represses the expression of C1orf61, suggesting that disruption of the miR-2392/C1orf61 axis contributes to HCC."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond these oncologic settings, miR-2392 is also implicated in fibrotic processes. In human skin keloid fibroblasts, the application of botulinum toxin A was shown to upregulate miR-2392; this upregulation leads to the downregulation of ZEB2, a target whose suppression is associated with reduced cell proliferation and migration as well as enhanced apoptosis and autophagy, thereby suggesting a potential therapeutic role for miR-2392 modulation in keloids."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMoreover, miR-2392 plays a critical role in the host response during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Circulating miR-2392 is directly involved with the viral machinery during host infection by driving the downstream suppression of mitochondrial genes and promoting inflammation, glycolysis, and hypoxia—key features of COVID-19 symptomatology. Its unique presence in the blood and urine of COVID-19 positive patients further underscores its potential both as a biomarker for minimally invasive viral detection and as a target for miRNA-based antiviral intervention."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jinjing Li, Tingyu Li, Yuanyuan Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "MAML3"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "WHSC1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.201601140RR"}], "href": "https://doi.org/10.1096/fj.201601140RR"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28512191"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28512191"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jinghui Yang, Chunsheng Li, Hang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.28477"}], "href": "https://doi.org/10.1002/jcp.28477"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30908634"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30908634"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zhanying Hou, Feixiang Fan, Po Liu "}, {"type": "b", "children": [{"type": "t", "text": "BTXA regulates the epithelial-mesenchymal transition and autophagy of keloid fibroblasts via modulating miR-1587/miR-2392 targeted ZEB2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20190679"}], "href": "https://doi.org/10.1042/BSR20190679"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31652445"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31652445"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "J Tyson McDonald, Francisco J Enguita, Deanne Taylor, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of miR-2392 in driving SARS-CoV-2 infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2021.109839"}], "href": "https://doi.org/10.1016/j.celrep.2021.109839"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34624208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34624208"}]}]}]}
|
| NCBI Gene ID | 100616495 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR2392 has 317 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 8 datasets.
Click the + buttons to view associations for MIR2392 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR2392 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR2392 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR2392 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR2392 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR2392 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR2392 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR2392 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR2392 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |